Villagonzalo, Cyrell Faith A.
HRN: 19-64-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2025
CEFUROXIME 750MG (VIAL)
05/03/2025
05/09/2025
IVTT
380mgv
Q8h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes